🇺🇸 Clindamycin palmitate hydrochloride dispersible tablet in United States

Clindamycin palmitate hydrochloride dispersible tablet (Clindamycin palmitate hydrochloride dispersible tablet) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Clindamycin palmitate hydrochloride dispersible tablet in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Clindamycin palmitate hydrochloride dispersible tablet approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Clindamycin palmitate hydrochloride dispersible tablet in United States?

Guangzhou Yipinhong Pharmaceutical CO.,LTD is the originator. The local marketing authorisation holder may differ — check the official source linked above.